Blurring the Lines: Beyond Using Transplant Eligibility to Guide Induction Therapy in Myeloma
DOI:
10.1182/hem.v22.1.202524
Publication Date:
2025-01-14T20:50:02Z
AUTHORS (4)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (13)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....